Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXC3BC
|
||||
| Drug Name |
1-(4-(3-aminobenzo[d]isoxazol-4-yl)phenyl)urea
|
||||
| Synonyms |
CHEMBL270070
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C14H12N4O2
|
||||
| Canonical SMILES |
NC(=O)Nc1ccc(cc1)c2cccc3onc(N)c23
|
||||
| InChI |
InChI=1S/C14H12N4O2/c15-13-12-10(2-1-3-11(12)20-18-13)8-4-6-9(7-5-8)17-14(16)19/h1-7H,(H2,15,18)(H3,16,17,19)
|
||||
| InChIKey |
QKEZZTSUDGCSDM-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | FL cytokine receptor | Target Info | [1587926] | ||
| Mast/stem cell growth factor receptor | Target Info | [1587926] | |||
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Hematopoietic cell lineage | |||||
| Pathways in cancer | |||||
| Transcriptional misregulation in cancer | |||||
| Acute myeloid leukemia | |||||
| Central carbon metabolism in cancerhsa04014:Ras signaling pathway | |||||
| Rap1 signaling pathway | |||||
| Endocytosis | |||||
| PI3K-Akt signaling pathway | |||||
| Melanogenesis | |||||
| Central carbon metabolism in cancer | |||||
| Pathway Interaction Database | C-MYB transcription factor network | ||||
| Signaling events mediated by Stem cell factor receptor (c-Kit) | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.